Fresenius Kabi is a global health care company that specializes in lifesaving medicines and technologies for infusion, transfusion and clinical nutrition. The company’s products and services are used to help care for critically and chronically ill patients. Our product portfolio comprised a comprehensive range of I.V. generic drugs, infusion therapies and clinical nutrition products as well as the medical devices for administering these products. Within transfusion technologies, Fresenius Kabi offers products for whole blood and blood components collection and processing as well as for transfusion medicine and cell therapies.
With our corporate philosophy of “caring for life,” we are committed to putting essential medicines and technologies in the hands of people who help patients and finding the best answers to the challenges they face.
Fresenius Kabi employs around 31,961 people worldwide. In 2013 the company reported sales of more than €4.9 billion. Fresenius Kabi operates aglobal network of around 65 sales and marketing organizations, 16 R&D centers and more than 70 production sites and compounding centers.